Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
daniel o'day
deals
fda
foundation medicine
foundationone cdx
foundationone heme
genentech
life sciences
national blog main
national top stories
new york blog main
osimertinib
roche
rucaparib (rubraca)
san francisco blog main
What
acquire
agreed
1
×
big
billion
broad
confidence
didn’t
foundation
gain
genentech
medicine
momentum
morning
panels
pay
pays
1
×
picked
profiling
recently
redux
remaining
rest
1
×
roche
share
stock
struggled
traction
tumor
vote
1
×
Language
Current search:
rest
×
agreed
×
vote
×
pays
×
@xconomy.com
6 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine